Skip to content

Impact of Muscle Relaxant Usage Strategy During Surgical Anesthesia on Postoperative Efficacy in Strabismus Surgery and Related Factors

A study of the effects of the strategy of using muscle relaxants in surgical anesthesia on the postoperative outcome of strabismus and related factors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108708
Enrollment
Unknown
Registered
2025-09-03
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Horizontal Strabismus

Interventions

General Anesthesia with Non-depolarizing Muscle Relaxant:General Anesthesia with Non-depolarizing Muscle Relaxant
General Anesthesia without Non-depolarizing Muscle Relaxant:General Anesthesia without Non-depolarizing Muscle Relaxant (NA Group)
Basic Anesthesia Group:Basic Anesthesia Only

Sponsors

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Adolescents between the age of 18 and 75(inclusive of ages 18 and 75); 2.Meets diagnostic criteria for horizontal strabismus and is eligible for strabismus surgery; 3.Scheduled to undergo strabismus surgery; 4.Free from significant external eye disease or fundus pathology, as confirmed by external eye, anterior segment, and fundus examinations; 5.Preoperative Intraocular Pressure (IOP): <= 25 mmHg; 6.ASA Physical Status Classification: <= Class III.

Exclusion criteria

Exclusion criteria: 1.Presence of special types of strabismus (e.g., thyroid eye disease, strabismus associated with systemic syndromes); 2.History of previous strabismus surgery; 3.Presence of an anticipated difficult airway; 4.Presence of any significant comorbidities that may impact surgery, including but not limited to coagulation disorders, abnormal liver or renal function, or congenital heart disease; 5.Presence of psychological or psychiatric disorders preventing adequate cooperation with the study; 6.Contraindication to or inability to tolerate one of the assigned anesthesia protocols (GA with non-depolarizing relaxant, GA without non-depolarizing relaxant, or basic anesthesia), precluding randomization; 7.Current participation in any other clinical trial.

Design outcomes

Primary

MeasureTime frame
The efficacy of strabismus surgery among the groups at 3 months postoperatively.;

Secondary

MeasureTime frame
Perioperative Objective Assessment Indicators;Eye movement, diplopia, and stereopsis at 3 months after strabismus surgery;Perioperative Subjective Assessment Indicators;

Countries

China

Contacts

Public ContactLin Li

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

jannetlee1300@163.com+86 21 23271699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026